olaparib maintenance retreatment in epithelial ovarian cancer
Published 2 years ago • 347 plays • Length 6:48Download video MP4
Download video MP3
Similar videos
-
9:36
maintenance olaparib following platinum-based chemotherapy for newly diagnosed ovarian cancer
-
1:04
olaparib maintenance therapy in ovarian cancer
-
2:10
asco: final overall survival results for olaparib maintenance in brca-mutated ovarian cancer
-
2:18
#esmo21 highlights on maintenance olaparib in ovarian cancer previously treated with parpi
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
2:18
lynparza (olaparib)- advanced epithelial ovarian, fallopian tube or primary peritoneal cancer
-
2:07
maintenance olaparib in patients with ovarian cancer
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
5:25
solo-1: frontline olaparib maintenance therapy in ovarian cancer
-
8:26
the impact of paola-1 on frontline treatment of ovarian cancer
-
3:37
olaparib in metastatic pancreatic cancer, the polo trial
-
39:03
the therapeutic potential of novel parp inhibitors in the clinic for epithelial ovarian cancer
-
3:58
the potential of parp inhibitors in ovarian cancer: paola-1, prima & velia
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
2:40
update on study 19 trial of olaparib in serous ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
0:43
efficacy of niraparib on pfs in patients with recurrent ovarian cancer
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
3:37
selecting patients to be treated with maintenance olaparib in the paola-1 trial